June Networking Event Summary

June 12 FOCM | GLSA Online Networking Event Recap

2024 Mid-year Highlights: A Successful Gathering

On June 12, FOCM and Global Life Sciences Alliance (GLSA) hosted an engaging online networking event focusing on the 2024 mid-year highlights. The event saw a robust turnout with 35 participants, blending familiar faces with new members, fostering a vibrant and dynamic discussion.

Opening Remarks and Industry Updates

Chris Matheus kicked off the event with a warm welcome, introducing new members and setting the stage with industry updates, news, and conference reviews. Participants shared their travel plans, locations, and upcoming trips, adding a personal touch to the professional gathering.

Networking and Collaborative Initiatives

The meeting adopted an open house format, encouraging participants to share their LinkedIn profiles for seamless networking. Chris also promoted the Women of Life Sciences virtual event and called for volunteers to judge the best giveaways at the upcoming DIA, led by Sheila Mahoney-Jewels (smj@lifescihub.com).

GLSA’s Mission and Conference Insights

The GLSA reiterated its mission to provide solutions for clinical trial issues. Michael Young, Brian Langin, Cameron Robinson, and Denise McNerney shared insights from the BIO conference, which boasted over 19,000 attendees. Michael also reviewed the heavily attended ASCO conference, noting a significant presence of first-time exhibitors and attendees.

Business Update and Market Analysis

Chris Matheus presented a detailed analysis of the business performance in the first half of the year. He discussed the initial surge in activity, followed by a slowdown in decision-making and funding optimism. Chris also covered the recent Federal Open Market Committee meeting, touching on global uncertainties and their potential impact on market trends, including the upcoming US presidential election and geopolitical tensions.

Advances in Drug Approvals and Precision Medicine

Recent advancements in drug approvals for NASH/fatty liver and Alzheimer’s were highlighted, with Michael Young discussing precision medicine’s role in oncology drug development. Notable Labs’ blood test and Keliomics’ ex vivo tumor models, presented at ASCO, were showcased as revolutionary innovations that could transform early-stage development.

AI and ML Applications in Clinical Trials

Chris Matheus explored the applications of AI and machine learning in clinical trials. He highlighted the potential for large-scale simulations and AI tools to predict patient enrollment and rank doctors. Despite enthusiasm, participants expressed skepticism regarding the current state of these technologies, particularly in patient enrollment and regulatory validation.

Challenges in Patient Enrollment and Hiring Trends

The discussion also addressed the challenges in patient enrollment post-COVID and hiring trends. Michael Young and Chris Matheus were optimistic about the resurgence of in-person conferences, citing high attendance at recent events. Lisamarie O’Brien highlighted the difficulties in hiring, emphasizing the need for smarter recruitment strategies and the role of AI in applicant tracking systems.

AI in Language Translation and Clinical Studies

Duncan Shaw highlighted the challenges of using AI for language translation and clinical studies, stressing the need for exactness and precision. The group echoed these sentiments, agreeing on the importance of patience and caution in evaluating AI’s potential in these areas.

AI and Budget Building Challenges

Mike O’Gorman shared concerns about AI’s capabilities in budget building, while Ira Snyder emphasized the limitations in obtaining precise budgetary details due to data quality issues.

Site Negotiations and Challenges

The slow progress in securing site contracts was discussed by Michael Young and Jane Myles, with Viljena Trask highlighting the competitive nature of oncology site selection. Eliana R. Burke shared an encounter with a highly experienced clinical trial site, and Ira Snyder emphasized the need for balanced negotiations for successful collaboration.

If you would like a copy of the slide set, email me at chris@focmnetworking.com

or if I did this correctly you can get it here: https://globallifesciencesalliance.com/wp-content/uploads/2024/06/2024-Mid-year.pdf

Looking Ahead

The next GLSA event is scheduled for July 17, with the subject yet to be determined. To stay updated on GLSA | FOCM events, sign up here. Stay tuned for more updates and we look forward to seeing you at our next event!



(First time attendees in bold)

Judy Woods

Jane Myles

Viljena Trask

Bill Dirkes

Tom Lo

Lauren Sherwood

Ira Snyder

Cameron Robinson

Eliana Rivera Burke

Jared Byer

Joan Chambers

Lori Leathers

Jon Carlson

Christine Martin

Hiro Matsushima

Duncan Shaw

Lauren Merante

Lisa Marie O’Brien

Michael Young

Marlyn Brookins

Dr. Syed Rooh ul Arifeen Naqvi

Irene Rivera

Julia Oxley

Yuko Terasawa



Denise McNerney

Jim Sarene

Kelvin Izevbekhai

Rocio Rayna Reyes

Timmina Williams

Chris Matheus

Leave a Reply

Your email address will not be published. Required fields are marked *